27.3.2023

Product liability rules under reform in the EU

The EU’s relatively old Product Liability Directive (85/374/EEC), adopted already in 1985, has been under the review of the European Commission in recent years.

In its current form, the Product Liability Directive establishes strict, i.e., no-fault, liability of the producer for a damage caused to a natural person and to a property used mainly for private purposes, which is caused by insufficient safety of the producer’s ‘products’, i.e., mainly movable objects and electricity. In Finland, the Product Liability Directive was implemented with the Finnish Product Liability Act (694/1990, as amended).

In 2018, the European Commission evaluated the Product Liability Directive and concluded that, despite the passing of time, it has remained mainly efficient and relevant, but that it also has some shortcomings. Among other things, the identified shortcomings were related to the current Product Liability Directive not adequately addressing the challenges posed by digital development and circular economy.

To update the product liability rules, the European Commission published a proposal for a new directive on liability for defective products on 28 September 2022, which would repeal the current Product Liability Directive (the proposal is available here). In the same connection, the European Commission also published a proposal for a directive on AI liability (available here); however, the latter will not be discussed further in this blog.

Digital development and circular economy taken into account in the proposed new Product Liability Directive

The proposed new Product Liability Directive includes the following key changes:

  • The definition of a ‘product’ is extended to include both tangible and intangible products. The product liability rules would thus not only cover movables and electricity, but also software and digital manufacturing files which mean digital versions or digital templates of a movable. In future, product liability could therefore exist, for example, for a damage caused by software.
  • The concept of damage is extended to cover, for example, the loss or corruption of data that is not used exclusively for professional purposes. According to the proposal, there would also be no maximum or minimum EUR limits for the compensation in future.
  • Companies making substantial modifications to the products that have already been placed on the market or put into service are also covered by the product liability rules in future in order to take into account circular business models.
  • The burden of proof remains on the injured person, who has to prove the damage they have suffered, the defectiveness of the product and the causal link between these two. However, since especially in complex cases, the injured may have difficulties in proving the damage, the proposal contains various presumption rules to lighten the burden of proof.
  • In future, Member States would be required to publish court judgments relating to product liability so that, in the interests of a more harmonised interpretation of the product liability rules, other national courts can take these judgments into account.  

What next?

The legislation project in Finland is still in early stages. In Finland, the Legal Affairs Committee issued a statement on the proposal for a new Product Liability Directive at the end of 2022, and the matter will proceed to committee reading in the spring. The Government has deemed it important that the product liability rules are updated to better reflect the impact of the digital age as well as the effects of circular economy and global value chains, but it also deemed that the proposal included a number of questions that require further discussion. The precise timeline of the legislation project has not yet been published, but the preparatory work will continue both at the EU level and the national level in the spring of 2023.

Latest references

We are acting as the lead counsel to Fortum in a cross-border transaction in which Fortum is selling its recycling and waste business. The business is sold to thematic impact investing firm Summa Equity through its portfolio company NG Group. The debt-free purchase price is approximately EUR 800 million. The transaction is subject to authority approval and customary closing conditions. Fortum’s recycling and waste business to be sold comprises municipal and industrial waste management and end-to-end plastics, metals, ash, slag and hazardous waste treatment and recycling services. These businesses are located in Finland, Sweden, Denmark and Norway and currently employ approximately 900 employees.
Case published 18.7.2024
We successfully represented Onses Finland Oy before the Finnish Market Court in an exceptionally extensive dispute concerning alleged trademark infringement and unfair business practice. Our client, Onses Finland Oy, is a Finnish sports drink company and the owner of the sports drink brand ONSE. In the spring of 2023, the Polish beverage company OSHEE Polska Sp. z o.o. filed legal action against our client, alleging that the ONSE trademarks and product packaging infringed the OSHEE trademarks. The plaintiff’s secondary claims concerned alleged slavish imitation of the OSHEE sports drink packaging and exploitation of the reputation of the plaintiff. The plaintiff based its suit on registered trademarks as well as allegedly established and reputed figurative and three-dimensional trademarks. The Market Court rejected all of the plaintiff’s claims. The Market Court held that the marks invoked in the suit were neither established nor marks with a reputation in Finland. As regards the registered trademarks, the Market Court found that there was no likelihood of confusion between the OSHEE and ONSE trademarks. As to the secondary claims, the Market Court held that the sports drink packaging used by the plaintiff was a normal beverage bottle, the design of which was partly determined by functional factors. The Market Court also found that there were several blue sports drinks available on the market and that the plaintiff’s product was not the first blue sports drink on the market. The plaintiff failed to show that its product packaging was original or well-known to the average consumer at the time of the launch of our client’s ONSE sports drink product, and the Market Court thus rejected the claims on slavish imitation and exploitation of reputation. The Market Court ordered the plaintiff to pay all of our client’s legal costs with statutory interest. The judgment (MAO:280/2024) is not final.
Case published 11.6.2024
We acted as the legal and ESG advisor to Mérieux Equity Partners on the acquisition of a majority stake in Labquality through a leveraged buyout by its buyout fund, Mérieux Participations 4. Existing shareholders of Labquality, including Cor Group and the management, will reinvest a portion of their proceeds into the company in connection with the transaction. Headquartered in Helsinki, Finland, Labquality is a Nordic player specialized in EQA, CRO activities and regulatory affairs, with a strong local presence in Central and Eastern Europe. The company provides a comprehensive array of services for the healthcare, medical technology, and pharmaceutical industries. The company, employing over 120 professionals and supported by a network of more than 150 external experts and consultants across its offices in Finland, Germany, and Poland, serves a diverse clientele of over 8,000 customers, including major pharmaceutical companies in over 60 countries. Mérieux Equity Partners (MxEP) is an AMF-accredited management company dedicated to equity investments in the Healthcare and Nutrition sectors. MxEP actively supports entrepreneurs and companies with differentiated products and services, giving them privileged access to its sector expertise and international network. The transaction will enable Labquality to pursue its buy & build strategy in Europe to accelerate its CRO activities while continuing strong and recurring growth in the EQA segment. Labquality will benefit from MxEP’s sector expertise and financial resources to achieve its ambition of becoming a leading European CRO and EQA platform, with fully integrated regulatory consulting capabilities to serve major customers across Europe.
Case published 4.12.2023
We advised Voisin Consulting Life Sciences (VCLS) on the acquisition of MedEngine, a leading medical science agency in the Nordics. MedEngine is a digitally minded, premium service provider for the pharmaceutical industry, built upon extensive academic expertise and years of experience in the industry. Founded in 2014, MedEngine has a strong presence across the Nordic countries with offices in Helsinki (Finland), Copenhagen (Denmark), and Stockholm (Sweden). Founded in 1997, VCLS provides end-to-end HealthTech solutions to support biotechnology, pharmaceutical and MedTech manufacturers throughout their product development. With offices in the US, France, UK, Switzerland, Denmark, Madagascar, India, and China, VCLS serves a broad range of developers and investors in HealthTech.
Case published 7.11.2023